Learn More
Medchemexpress LLC SPR719 | 1384984-18-2 | 99.4% | 10 MG

Supplier: Medchemexpress LLC HY1293010MG
SPR719 (VXc-486) is an orally active gyrase B inhibitor with bactericidal activity. It potently inhibits multiple agent-sensitive and drug-resistant isolates of Mycobacterium tuberculosis, making it promising for research into lung diseases caused by non-tuberculous mycobacteria (NTM).
- Potently inhibits multiple agent-sensitive and drug-resistant isolates of Mycobacterium tuberculosis.
- Shows bactericidal activity.
- Research compound for lung diseases caused by non-tuberculous mycobacteria (NTM).
- Orally active gyrase B inhibitor.
- Inhibits M. tuberculosis replication in macrophages.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.